PR

ProBiotix Health Plc

Develops scientifically validated probiotics for cardiometabolic health for consumers & partners.

PBX | Aquis Stock Exchange

Overview

Corporate Details

ISIN(s):
GB00BLNBFR86
LEI:
98450048683CF0388C30
Country:
United Kingdom
Address:
First Floor Zucchi Suite, WF4 1AB Wakefield
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ProBiotix Health Plc is a life sciences company that develops and commercializes scientifically validated, probiotic-based microbiome solutions. The company focuses on tackling lifestyle conditions, with a primary emphasis on cardiometabolic health. Its core technology is the patented and award-winning Lactobacillus plantarum strain, LPLDL®, which has been demonstrated in human clinical trials to help reduce cholesterol and blood pressure. ProBiotix Health provides its proprietary strain and finished product formulations, such as the YourBiotix and CholBiome lines, to both consumers and industry partners worldwide. The company's development process is supported by collaborations with leading universities, research institutes, and a team of internationally recognized scientific advisors to ensure product efficacy and safety.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-03 08:30
Delisting Announcement
Move from Access to Apex Segment of Aquis
English 12.1 KB
2025-10-23 08:00
Board/Management Information
Appointment of Aquis Corporate Adviser
English 10.1 KB
2025-10-20 08:00
Regulatory Filings
New Commercial Partnership in Australia
English 16.5 KB
2025-10-14 15:00
Director's Dealing
Director/PDMR Shareholding
English 20.3 KB
2025-10-14 08:00
Regulatory Filings
New Commercial Partnership in Sweden
English 15.7 KB
2025-10-13 08:00
Earnings Release
Q3 2025 Trading Update and Grant of Options
English 14.2 KB
2025-09-08 08:00
Earnings Release
Unaudited Interim Results to 30 June 2025
English 206.3 KB
2025-07-15 08:00
Earnings Release
Trading Update and Notice of Results
English 16.1 KB
2025-06-27 13:35
AGM Information
Result of AGM and Notice of Trading Update
English 10.7 KB
2025-03-28 08:00
Regulatory Filings
New Partnership Agreement in South Korea
English 16.2 KB

Automate Your Workflow. Get a real-time feed of all ProBiotix Health Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ProBiotix Health Plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ProBiotix Health Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Develops medical devices, diagnostics, nutritionals, and pharmaceuticals for global health.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900

Talk to a Data Expert

Have a question? We'll get back to you promptly.